Previous Close | 1.7700 |
Open | 1.7500 |
Bid | 0.0000 x 1000 |
Ask | 0.0000 x 2200 |
Day's Range | 1.7400 - 1.7700 |
52 Week Range | 1.0200 - 1.9100 |
Volume | |
Avg. Volume | 195,217 |
Market Cap | 198.132M |
Beta (5Y Monthly) | 0.92 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4100 |
Earnings Date | Nov 12, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.00 |
If you want to know who really controls Savara Inc. ( NASDAQ:SVRA ), then you'll have to look at the makeup of its...
AUSTIN, Texas, July 11, 2022--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the acceptance of three abstracts for poster presentation at the ERS International Congress 2022 to be held in-person and virtually, September 4-6, 2022 in Barcelona, Spain.
Savara, The LGL Group, and Harte Hanks are part of zacks Screen of the Week article.